{
    "id": "c2e18240-ed8e-4b5d-9fb4-3ce104d87a38",
    "indications": "VIGAFYDE is indicated as monotherapy for the treatment of i nfantile spasms in pediatric patients 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss ( 1 )",
    "contraindications": "VIGAFYDE is a concentrated formulation as compared to other vigabatrin products. Verify the strength and the dose of the product prior to prescribing, dispensing, and administering ( 2.1 ) Initiate at a daily dosage of 50 mg/kg (25 mg/kg twice daily); increase total daily dosage every 3 days, in increments of 25 mg/kg/day to 50 mg/kg/day, up to a maximum daily dosage of 150 mg/kg (75 mg/kg twice daily) ( 2.2 )",
    "warningsAndPrecautions": "VIGAFYDE (vigabatrin) oral solution contains 100 mg/mL vigabatrin. It is a clear, colorless to light yellow, peppermint-flavored solution supplied in a white opaque high-density polyethylene (HDPE) 150 mL bottle in a carton (NDC 80789-003-15).",
    "adverseReactions": "None.",
    "ingredients": [
        {
            "name": "VIGABATRIN",
            "code": "GR120KRT6K"
        }
    ],
    "organization": "Upsher-Smith Laboratories, LLC",
    "name": "VIGAFYDE",
    "effectiveTime": "20250227"
}